General Announcement for PLC

06/09/2021

MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") MEMORANDUM OF UNDERSTANDING ("MOU") WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") - MASTER SERVICE AGREEMENT BETWEEN ITS WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED AND WITH LIMITED LIABILITY COMPANY "HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF

UCREST BERHAD

Type Announcement
Subject MEMORANDUM OF UNDERSTANDING
Description 
UCREST BERHAD ("UCREST" OR "THE COMPANY") 
MEMORANDUM OF UNDERSTANDING ("MOU") WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF")
- MASTER SERVICE AGREEMENT BETWEEN ITS WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED AND WITH LIMITED LIABILITY COMPANY "HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF

Further to the announcements made by the Company on the Memorandum of Understanding (“MOU”) between Company and Russian Direct Investment Fund (“RDIF”) on 9 April 2021, 14 April 2021, 28 April 2021, 19 May 2021, 20 May 2021 and 9 June 2021, the Board of Directors of UCrest (“Board”) is pleased to announce that its wholly owned subsidiary, UCrest Technology Limited ("UTL") had on 6 September 2021 entered into a Master Service Agreement with Limited Liability Company "Human Vaccine" ("Human Vaccine"), a wholly owned subsidiary of RDIF for production of Sputnik V Vaccines (“Vaccine” or “Products”), following the MOU signed between their respective parent companies, UCrest and RDIF in April 2021.

 

Futher details of the Master Service Agreement are set out in the attachment below.

 

This announcement is dated 6 September 2021.


Please refer attachment below.


Announcement Info

Company Name UCREST BERHAD
Stock Name UCREST
Date Announced 06 Sep 2021
Category General Announcement for PLC
Reference Number GA1-06092021-00023


Related Announcements for UCREST
Date Title
20/07/2022 OTHERS UCREST BERHAD ("UCREST" OR "THE COMPANY") - SERVICE LEVEL AGREEMENT WITH MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD
23/05/2022 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") - MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED ("UTL") AND LIMITED LIABILITY COMPANY HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
14/03/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING UCREST BERHAD ("UCREST") PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN UCREST, PURSUANT TO THE GENERAL MANDATE OBTAINED FROM THE COMPANY'S SHAREHOLDERS ("PRIVATE PLACEMENT")
03/03/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING UCREST BERHAD ("UCREST") PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN UCREST, PURSUANT TO THE GENERAL MANDATE OBTAINED FROM THE COMPANY'S SHAREHOLDERS ("PRIVATE PLACEMENT")
23/02/2022 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") - MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
30/11/2021 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") (I) MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") (II) MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED, AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
26/11/2021 (I) MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") (II) MASTER SERVICE AGREEMENT BETWEEN UCREST BERHAD'S ("UCREST") WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED, AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF
24/11/2021 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING ("MOU") WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") - MASTER SERVICE AGREEMENT ("MSA") BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED ("UTL") AND LIMITED LIABILITY COMPANY HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF
29/10/2021 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS DURING CLOSED PERIOD
01/10/2021 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : INTENTION TO DEAL DURING CLOSED PERIOD